Renal Cancers Terminated Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00704938Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic CancerTreatment